-
1
-
-
57849117384
-
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
-
19097774 10.1016/j.ejca.2008.10.026 1:STN:280:DC%2BD1M%2Fgs12rug%3D%3D
-
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). European Journal of Cancer. 2009;45:228-47.
-
(2009)
European Journal of Cancer
, vol.45
, pp. 228-247
-
-
Eisenhauer, E.A.1
Therasse, P.2
Bogaerts, J.3
Schwartz, L.H.4
Sargent, D.5
Ford, R.6
Dancey, J.7
Arbuck, S.8
Gwyther, S.9
Mooney, M.10
Rubinstein, L.11
Shankar, L.12
Dodd, L.13
Kaplan, R.14
Lacombe, D.15
Verweij, J.16
-
2
-
-
84865332134
-
Modeling tumor growth in oncology
-
L. Bonate D.R. Howard (eds) Springer New York 10.1007/978-1-4419-7937-7-1
-
Bonate L. Modeling tumor growth in oncology. In: Bonate PL, Howard DR, editors. Pharmacokinetics in drug development: advances and applications. New York: Springer; 2011. p. 1-19.
-
(2011)
Pharmacokinetics in Drug Development: Advances and Applications
, pp. 1-19
-
-
Bonate, L.1
-
3
-
-
67651171223
-
Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug development
-
19440187 10.1038/clpt.2009.64 1:CAS:528:DC%2BD1MXovFOrt7o%3D
-
Wang Y, Sung C, Dartois C, Ramchandani R, Booth BP, Rock E, et al. Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug development. Clinical Pharmacology and Therapeutics. 2009;86:167-74.
-
(2009)
Clinical Pharmacology and Therapeutics
, vol.86
, pp. 167-174
-
-
Wang, Y.1
Sung, C.2
Dartois, C.3
Ramchandani, R.4
Booth, B.P.5
Rock, E.6
Gobburu, J.7
-
4
-
-
70249134646
-
Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics
-
19636014 10.1200/JCO.2008.21.0807 1:CAS:528:DC%2BD1MXhtF2jtL3F
-
Claret L, Girard P, Hoff PM, Van Custem E, Zuideveld KP, Jorga K, et al. Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics. Journal of Clinical Oncology. 2009;27:4103-8.
-
(2009)
Journal of Clinical Oncology
, vol.27
, pp. 4103-4108
-
-
Claret, L.1
Girard, P.2
Hoff, P.M.3
Van Custem, E.4
Zuideveld, K.P.5
Jorga, K.6
Fagerberg, J.7
Bruno, R.8
-
5
-
-
0033635161
-
Parameter estimation in a Gompertzian stochastic model for tumor growth
-
11129463 10.1111/j.0006-341X.2000.01076.x 1:STN:280: DC%2BD3M7it1Cntw%3D%3D
-
Ferrante L, Bompadre L, Possati L, Leone L. Parameter estimation in a Gompertzian stochastic model for tumor growth. Biometrics. 2000;56:1076-81.
-
(2000)
Biometrics
, vol.56
, pp. 1076-1081
-
-
Ferrante, L.1
Bompadre, L.2
Possati, L.3
Leone, L.4
-
6
-
-
84966166281
-
Dynamics of tumor growth
-
10.1038/bjc.1964.55
-
Laird AK. Dynamics of tumor growth. British Journal of Cancer. 1964;18:490-502.
-
(1964)
British Journal of Cancer
, vol.18
, pp. 490-502
-
-
Laird, A.K.1
-
7
-
-
0024214663
-
A Gompertzian model of the human breast cancer growth
-
3191483 1:STN:280:DyaL1M%2FltFOltg%3D%3D
-
Norton L. A Gompertzian model of the human breast cancer growth. Cancer Research. 1988;48:7067-81.
-
(1988)
Cancer Research
, vol.48
, pp. 7067-7081
-
-
Norton, L.1
-
8
-
-
0031457714
-
Quantitation and Gompertzian analysis of tumor growth
-
10.1023/A:1005906900231 1:STN:280:DyaK1c7jvVOluw%3D%3D
-
Rygaard K, Spang-Thomsen M. Quantitation and Gompertzian analysis of tumor growth. Breast Cancer Research Treatment. 1997;46:303-12.
-
(1997)
Breast Cancer Research Treatment
, vol.46
, pp. 303-312
-
-
Rygaard, K.1
Spang-Thomsen, M.2
-
9
-
-
0023233021
-
The biological foundation of the Gompertz Model
-
3557692 10.1016/0020-7101(87)90012-2 1:STN:280:DyaL2s7msVKjtw%3D%3D
-
Xu X. The biological foundation of the Gompertz Model. International Journal of Biomedical Computing. 1987;20:35-9.
-
(1987)
International Journal of Biomedical Computing
, vol.20
, pp. 35-39
-
-
Xu, X.1
-
11
-
-
80051725760
-
Variability in lung tumor measurements on repeat computed tomography scans taken within 15 min
-
10.1200/JCO.2010.33.7071
-
Oxnard GR, Zhao B, Sima CS, Ginsberg MS, James LP, Lefkowitz RA, et al. Variability in lung tumor measurements on repeat computed tomography scans taken within 15 min. Journal of Clinical Oncology. 2011;23:3114-9.
-
(2011)
Journal of Clinical Oncology
, vol.23
, pp. 3114-3119
-
-
Oxnard, G.R.1
Zhao, B.2
Sima, C.S.3
Ginsberg, M.S.4
James, L.P.5
Lefkowitz, R.A.6
Guo, P.7
Kris, M.G.8
Schwartz, L.H.9
Riely, G.J.10
-
12
-
-
0038352143
-
Interobserver and intraobserver variability in measurement of non-small cell carcinoma lung lesions: Implications for assessment of tumor response
-
12829678 10.1200/JCO.2003.01.144
-
Erasmus JJ, Gladish GW, Broemeling L, Sabloff BS, Truong MT, Herbst RS, et al. Interobserver and intraobserver variability in measurement of non-small cell carcinoma lung lesions: implications for assessment of tumor response. Journal of Clinical Oncology. 2003;21:2574-82.
-
(2003)
Journal of Clinical Oncology
, vol.21
, pp. 2574-2582
-
-
Erasmus, J.J.1
Gladish, G.W.2
Broemeling, L.3
Sabloff, B.S.4
Truong, M.T.5
Herbst, R.S.6
Munden, R.F.7
|